The personalized skin care trend is moving forward with scientific options—EpigenCare hopes to enter this growing market by connecting skin care companies with consumers based on their epigenetic profile.
According to the company, 45% of adults are interested in a scientific test such as this for personalized skin care.
EpigenCare analyzes the epigenome—i.e., the chemical signals managing genetic activities—to determine skin qualities for personalized results. As with many consumer DNA kits, EpigenCare consumers complete a non-invasive DNA collection process before sending it back to the company for analysis. EpigenCare then performs epigenetically targeted sequencing, which identifies epigenetic markers for the following skin quality indicators:
- Aging;
- Firmness and elasticity;
- Moisture retention;
- DNA damage and repair;
- Cell regeneration;
- Sensitivity response;
- Oxidation and antioxidation; and
- Pigmentation.
These indicators are then matched with active ingredients—such as alpha-hydroxy acids, hydroquinone, retinol (vitamin A) and L-ascorbic acid (vitamin C)—that have the potential to epigenetically impact the skin profile. The company then assembles a list of recommended name brand and boutique skin care products already on the market.
The company’s recurring business model allows consumers to track their skin care routine’s effectiveness. It will also offer “The EpigenCare Network” web platform, where skin care companies place auto-screened products in consumer’s recommendation sections. All of this is done anonymously with blockchain technology.
EpigenCare plans to launch the full skin care test to the public in Q4 2018 and predicts that the market for skin care tests may reach $20–30 billion.
